Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/TRAIL-Cisplatin combination therapy in cervical cancer
- Narayan, G.
- Xie, D.
- Ishdorj, G.
- Scotto, L.
- Mansukhani, M.
- Pothuri, B.
- Wright, J.D.
- Kaufmann, A.M.
- Schneider, A.
- Arias-Pulido, H.
- Murty, V.V.
ISSN: 1098-2264, 1045-2257
Datum der Publikation: 2016
Ausgabe: 55
Nummer: 2
Seiten: 177-189
Art: Artikel